Articles related to LIPID HEALTH

This recent research highlights the potential impact of lipid accumulation on Alzheimer’s disease, focusing on the differential role of APOE gene variants in lipid transport within the brain, a crucial aspect that may shape future therapeutic directions.

Physicians should be aware of the evolving research regarding statins and dementia. Recent studies provide mixed evidence, with some suggesting a potential protective effect of statins against dementia, underscoring the necessity for individualized patient assessments.

Empower your patients with a multifaceted approach to cholesterol management, emphasizing the powerful combination of dietary adjustments, physical activity, and lifestyle changes alongside medical therapies.

Stay updated on the USPSTF’s stance on lipid disorder screening in asymptomatic youth—a topic that directly impacts our strategies for early detection and intervention.

A recent Danish cohort study reveals that older adults (≥75 years) may experience a more pronounced LDL-C reduction with low- to moderate-intensity statins than their younger counterparts. This finding emphasizes the need to consider age when prescribing statin therapy.

Bempedoic acid is currently approved for two patient subgroups. This 3-year, double-blind, randomized, placebo-controlled trial examined cholesterol-lowering and CV protective effects in a broader population of approximately 14,000 patients with elevated cholesterol who were unable or unwilling to take statins. The drug was 21% more effective than placebo at reducing LDL in this trial. There was a small but significant reduction in primary events of CV-related death, MI, stroke, or coronary revascularization.